Researchers explore osteopontin's potential to transform chronic kidney disease treatment

A new analysis examines whether osteopontin—a naturally occurring protein—could bridge the gap between laboratory discovery and clinical use for chronic kidney disease patients. The finding matters because CKD affects millions globally and current treatments remain limited, making any advance in disease management potentially significant for healthcare systems and pharmaceutical development.

Originaltitel: Will osteopontin bridge the gap towards clinical application in chronic kidney disease?